Publications
SELECTED PUBLICATIONS
-
Núñez-Sánchez MA, Martinez-Sanchez MA, Martínez-Montoro JI, Balaguer-Román A, Murcia-García E, Fernández-Ruiz VE, Ferrer-Gómez M, Martínez-Cáceres CM, Sledzinski T, Frutos MD, Hernández-Morante JJ, Fernández-García JC, Queipo-Ortuño MI, Ruiz-Alcaraz AJ, Mika A, Ramos-Molina B (CA). 2024. Lipidomic analysis reveals alterations in hepatic FA profile associated with MASLD stage in patients with obesity. J Clin Endocrinol Metab. doi: doi.org/10.1210/clinem/dgae028 | PMID: 38217869
-
Colosimo S, Martinez-Sanchez MA, Balaguer-Roman A, Fernandez-Ruiz VE, Nuñez-Sanchez MA, et al., Marchesini G, Ramos-Molina B. 2023. A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: a pilot study. Nutr Metab Cardiovasc Dis. doi: 10.1016/j.numecd.2023.12.008 | PMID: 38220504
-
Marsal-Beltran A, Rodríguez-Castellano A, et al, Ramos-Molina B, Aspichueta P, Joven J, Fernández-Real JM, Quer JC, Valverde ÁM, Pardo A, Vendrell J, Ceperuelo-Mallafré V, Fernández-Veledo S. 2023. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD. Metabolism. doi: 10.1016/j.metabol.2023.155630 | PMID: 37315889
-
Khanmohammadi S, Ramos-Molina B (CFA), Kuchay MS. 2023. NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors. Diabetes Metab Syndr. doi: 10.1016/j.dsx.2023.102788 | PMID: 37302383
-
Niño-Narvión J, Rojo-López MI, et al., Ramos-Molina B, Mauricio D, Julve J. 2023. NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota. Nutrients. doi: 10.3390/nu15132992 | PMID: 37447318
-
Zheng K, Hao F, Medrano-Garcia S, et al., Ramos Molina B, Herranz JM, Ávila MA, Nevzorova YA, Fernández-Malavé E, Cubero FJ. 2023. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis. Cell Death Dis. doi: 10.1038/s41419-023-06029-y | PMID: 37563155
-
Talamantes S, Lisjak M, Gilglioni EH, Llamoza-Torres CJ, Ramos-Molina B, Gurzov EN. 2023. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports. doi: 10.1016/j.jhepr.2023.100811 | PMID: 37575883
-
Babiy B, Ramos-Molina B (CFA), Ocaña L, et al., Pastor O. 2023. Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease. BBA Mol Cell Biol Lipids. doi: 10.1016/j.bbalip.2023.159318 | PMID: 37059386
-
Núñez-Sánchez MA, Jiménez-Méndez A., Suárez-Cortés M, et al., Ramos-Molina B (CA). 2023. Inherited epigenetic hallmarks of childhood obesity derived from prenatal exposure to obesogens. Int J Environ Res Public Health. doi: 10.3390/ijerph20064711 | PMID: 36981620
-
Martinez-Montoro JI, Núñez-Sánchez MA (CFA), Martinez-Sánchez MA, et al., Fernandez-Garcia JC, Mika A, Ramos-Molina B. 2023. Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case-control study. Obesity (Silver Spring). doi: 10.1002/oby.23711 | PMID: 36981620
-
Martinez-Sánchez MA, Balaguer-Roman A, Fernandez-Ruiz V, et al., Ruiz-Alcaraz AJ, Núñez-Sánchez MA (CA), Ramos-Molina B. 2023. Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesity. Surg Obes Relat Dis. doi: 10.1016/j.soard.2022.12.041 | PMID: 36842931
-
Ruiz-Alcaraz AJ, Núñez-Sánchez MA (CFA), Asensio Ruiz MA, et al., Ramos-Molina B (CA), Lozano-Pérez AA. 2023. Optimizing the Preparation of Silk Fibroin Nanoparticles and Their Loading with Polyphenols: Towards a More Efficient Anti-Inflammatory Effect on Macrophages. Pharmaceutics. doi: 10.3390/pharmaceutics15010263 | PMID: 36678894
-
Lee SM, Muratalla J, Karimi S, Diaz-Ruiz A, Frutos MD, Guzman G, Ramos-Molina B, Cordoba-Chacon J. 2023. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci. doi: 10.1007/s00018-022-04629-z | PMID: 36629912
-
Coppola I, Brouwers B, Walker L, Alar C, Meulemans S, White A, Ramos-Molina, B. (CA), Creemers JWM. 2022. Loss of hypothalamic Furin affects POMC to proACTH cleavage and feeding behavior in high-fat diet-fed mice. Mol Metab. doi: 10.1016/j.molmet.2022.101627 | PMID: 36374777.
-
Núñez-Sánchez MA, Herisson FM, Keane JM, García-González N, Rossini V, Pinhiero J, Daly J, Bustamante-Garrido M, Hueston CM, Patel S, Canela N, Herrero P, Claesson MJ, Melgar S, Nally K, Caplice NM, Gahan CGM. 2022. Microbial bile salt hydrolase activity influences gene expresión profiles and gastrointestinal maturation in infant mice. Gut Microbes. doi: 10.1080/19490976.2022.2149023 | PMID: 36420990.
-
Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina, B. (CA). 2022. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. doi: 10.21037/hbsn-22-355 | PMID: 36268240
-
Fernández-García JC, Barrios-Rodríguez R, Asenjo-Plaza M, Ramos-Molina, B., Molina-Vega M, Guzmán-Guzmán A, Moreno-León L, Yubero-Serrano EM, Rius-Díaz F, Valdés S, Martínez-González MÁ, Jiménez-Moleón JJ, Tinahones FJ. 2022. Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial. Metabolism. doi: 10.1016/j.metabol.2022.155290 | PMID: 35985506
-
Kuchay MS, Martínez-Montoro JI, Kaur P, Fernández-García JC,Ramos-Molina, B. (CA). 2022. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Res Rev. doi: 10.1016/j.arr.2022.10169. | PMID: 35843589
-
Martinez-Montoro, J.I.; Kuchay, M.S.; Balaguer-Roman, A.; Martinez-Sanchez, M.A.; Frutos, M.D.; Fernandez-Garcia, J.C.; Ramos-Molina, B. (CA). 2021. Gut Microbiota and Related Metabolites in the Pathogenesis of Non-Alcoholic Steatohepatitis and its Resolution after Bariatric Surgery. Obesity Reviews. doi: 10.1111/obr.13367 | PMID: 34729904
-
Brouwers, B.; Coppola, I.; Vints, K.; et al; Ramos-Molina, B. (CA); Creemers, J.W. 2021. Loss of Furin in β cells induces an mTORC1-ATF4 anabolic pathway that leads to β cell dysfunction. Diabetes. 2020 Dec 4:db200474. doi: 10.2337/db20-0474 | PMID: 33277337
CA: Corresponding Author.
CFA: Co-First Author.